Editorial Board
About Us
Contact Us
Newsletters
FAQ
Issue Archive
Home
We've Got Answers
News
Daily Medical News
Conference Coverage
Medical News Round-Up
Newsletters
Features
Departments
A Most Unusual Case
Dermatologic Look-A-Likes
Dermatology Dx
Diagnostic Challenge
Drug Update from MPR
Medicine and the Law
Quick Digest
Stat Consult
Guidelines at a Glance
Clinical Pearls
myCME
MPR Drug Database
Hot Topics:
Dermatology
Women's Health
Diabetes
Heart Disease
Hypertension
Preventive Medicine
Polls & Surveys
Cartoons
RSS
|
Login
|
Register
Drug Therapy
Gout drug prevents BP jump in men
December 17, 2009
Allopurinol, which is used to lower uric acid levels to counteract gout, may also reduce BP that has been raised by a diet high in fructose, the only common sugar currently known to increase uric acid levels.
Drug-drug interaction stumps doctors
September 17, 2009
A study found that physicians, nurse practitioners, and physician assistants incorrectly identified more than 50% of drug pairs with potentially dangerous interactions.
FDA accepts application for once-weekly exenatide
July 13, 2009
The agency will review the New Drug Application submitted for once-weekly exenatide as a subcutaneous injectable treatment of type 2 diabetes.
FDA mandates smoking-cessation warnings
By Traci Dantoni July 02, 2009
The FDA is now requiring the popular smoking-cessation drugs varenicline and bupropion to carry the highest safety warning amid reports of suicide and depression.
Statins may prevent PSA relapse
July 01, 2009
After radical prostatectomy for prostate cancer, men who took the medications had a 30% lower risk.
MPR drug database available to mobile devices
June 08, 2009
The popular service adds handhelds to its desktop and laptop offerings, including Blackberry and Palm.
New HIV strategies presented at CROI
By Kevin J. Armington, MD May 26, 2009
Cortlandt Forum correspondent Kevin J. Armington, MD, reports on highlights from the 16th Annual Conference on Retroviruses and Opportunistic Infections (CROI), which took place recently in Montreal.
New evidence points to earlier start for HIV treatment
May 11, 2009
Starting antiretroviral therapy for HIV when CD4 counts are as high as 500 cells/mm3 reduces mortality risks by as much as 94%, according to several recent studies.
Boosting pancreatic beta cells
Question by Shah Niranjan, MD, Roslyn Heights, N.Y.; response by Lyle Mitzner, MD April 20, 2009
Is there a role for sitagliptin in enhancing pancreatic beta-cell function or quantity? Our expert discusses the issue.
Hair loss as a side effect of statins?
Question by Jyoti Khatri, MD, Omaha; response by Peter F. Cohn, MD April 15, 2009
A 63-year-old woman wants to discontinue the simvastatin (Zocor) 10 mg she is taking for hypercholesterolemia because she believes the medication is causing her to lose her hair. Is there any evidence supporting this side effect of Zocor?
Switch meds for this patient with diabetes?
Question from Mostafa M. Rehab, MD, Greensburg, Ind; response by Lyle D. Mitzner, MD March 27, 2009
Can this patient's insulin glargine dose be increased? If so, how high? Should he be switched to insulin detemir?
Symbyax approved for treatment-resistant depression
March 23, 2009
The FDA has approved a new indication for Eli Lilly's Symbyax(R) (olanzapine and fluoxetine HCl capsules). Symbyax is the first drug approved by the FDA for the acute treatment of treatment-resistant depression.
Too many alerts mar e-prescriptions
March 20, 2009
Does prescribing software give you too much of a good thing with its constant drug warnings? Alert fatigue could waste time and, worse, harm patients.
Anti-anxiety effect of zolpidem
Question from Eric Busse and Shailendra K. Saxena, MD, PhD, Omaha; response by David Brody, MD March 16, 2009
Do any data support the use of zolpidem as an antianxiolytic agent?
FDA approves insomnia drug
March 16, 2009
Edluar (formerly Sublinox) 5 mg and 10 mg sublingual tablets can be used for short-term treatment of insomnia characterized by difficulties with sleep initiation.
Persistent Nocturia? Diuretic May Help
March 11, 2009
Adding a diuretic to alpha-blocker therapy may be an effective second-line treatment for nocturia in some men with lower urinary tract symptoms, according to researchers.
FDA approves Symbicort for COPD
March 03, 2009
The FDA has approved Symbicort 160/4.5 micrograms (budesonide/formoterol fumarate dehydrate, from AstraZeneca) for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease.
Apidra SoloSTAR insulin pen approved
February 27, 2009
The FDA has approved a new prefilled disposable insulin pen from sanofi-aventis.
From the Editorial Board: I thought I knew how to manage diabetes
By Daniel G. Federman, MD February 19, 2009
The ACCORD, ADVANCE, and other trials have suggested a shifting landscape in diabetes treatment. After you read what this physician thinks, let us know your thoughts.
Subcutaneous vs. IV insulin
Question from Dennis A. Fito, MD, Oklahoma City; response by Lyle Mitzner, MD February 17, 2009
Can administering subcutaneous insulin every one to two hours substitute of IV insulin therapy?
Contemporary insulin administration
Question asked by Steven Schwartz, MD, Bronx, N.Y., and answered by Lyle Mitzner, MD February 05, 2009
An update on administering insulin
Cleviprex
February 05, 2009
An IV calcium channel blocker to reduce BP from The Medicines Company
Antidepressants ease fibromyalgia complaints
By Myra Dembrow February 05, 2009
Antidepressants are effective against most symptoms, a meta-analysis of clinical trials reports.
Popular drugs lower PSA levels
January 21, 2009
According to a pair of recent studies, two of the most commonly used classes of medication—statins and nonsteroidal anti-inflammatory drugs (NSAIDs)—may compromise already controversial cancer screenings by lowering serum levels of prostate-specific antigen.
Autoimmune and vasculitic renal diseases
Question asked by Dennis Fito, MD, Oklahoma City, and answered by Edgar V. Lerma, MD January 09, 2009
The etiology, diagnosis, and treatment of autoimmune and vasculitic renal diseases
ARBs and ACE inhibitors for proteinuria
Question asked by Absar Qureshi, MD, Columbus, Ohio, and answered by Edgar V. Lerma, MD January 09, 2009
Can we prescribe the ARBs and the ACE inhibitors in insurance company formularies for the treatment of diabetic nephropathy, or must we push for specific agents?
Lowering LDL cholesterol still important, says FDA
January 09, 2009
The agency reaffirmed its position that elevated amounts of LDL are a risk factor for cardiovascular diseases such as heart attack, stroke, and sudden death and that lowering LDL cholesterol reduces the risk of these diseases.
Inhaled steroids for pregnant patients
Question by Absar Quereshi, MD, Columbus; answer by R. Steven Tharratt, MD, MPVM January 07, 2009
Are the recommendations for inhaled steroids different for pregnan patients?
Non-group A strep: A continuing debate
Question by Russell W. Piper, MD, Washington, Pa., and answer by Cedric W. Spak, MD, MPH January 05, 2009
A reader seeks conclusive evidence-based data that "treatment is definitely indicated" in patients with significant clinical complaints and positive testing for non-group A strep.
FDA approves new extended release painkiller
January 05, 2009
The agency gives the nod to Ryzolt (tramadol HCl extended-release tablets), a once-daily formulation of the analgesic tramadol. Ryzolt is indicated for the management of moderate-to-moderately severe chronic pain in adults who require long-term, around-the-clock pain treatment.
Latest News
Self-monitoring in non-insulin-dependent diabetes
Invest in companies with advantages that competitors cannot duplicate
Daytime sleepiness may point to Alzheimer's risk
What to look for with drug-induced urticaria
ACS updates prostate screening recommendations
What lies behind the vitamin D revolution?
Concurrent oral antibiotics for acne and acute illness?
Recurrent periorbital dermatitis
Pressure-induced bumps and erythema
C. difficile on the rise in outpatient settings
Most Popular
Most Emailed
Most Recent
What lies behind the vitamin D revolution?
Erythematous truncal plaques
Concurrent oral antibiotics for acne and acute illness?
Recurrent periorbital dermatitis
ACS updates prostate screening recommendations
Self-monitoring in non-insulin-dependent diabetes
Daytime sleepiness may point to Alzheimer's risk
Pressure-induced bumps and erythema
Cutaneous symptoms reveal an unintentionally obscured disease
C. difficile on the rise in outpatient settings
What lies behind the vitamin D revolution?
ACS updates prostate screening recommendations
Cutaneous symptoms reveal an unintentionally obscured disease
Managing UTIs in debilitated patients
Self-monitoring in non-insulin-dependent diabetes
Invest in companies with advantages that competitors cannot duplicate
Daytime sleepiness may point to Alzheimer's risk
What to look for with drug-induced urticaria
Concurrent oral antibiotics for acne and acute illness?
Recurrent periorbital dermatitis
Self-monitoring in non-insulin-dependent diabetes
Invest in companies with advantages that competitors cannot duplicate
Daytime sleepiness may point to Alzheimer's risk
What to look for with drug-induced urticaria
ACS updates prostate screening recommendations
What lies behind the vitamin D revolution?
Concurrent oral antibiotics for acne and acute illness?
Recurrent periorbital dermatitis
Pressure-induced bumps and erythema
C. difficile on the rise in outpatient settings
Popular Topics
Allergic Reaction
Alzheimer’s Disease And Dementias
Bacterial Infection
BICUSPID AORTIC VALUE
C Difficile
Cancer
Cardiology
Cognitive Performance
Dermatographia
Dermatology
Diabetes
Drug Allergy
Drug-Induced Allergy
Erythematous Plaques
Family Medicine
Family Physician
Gastroenterology
Glucose Control
Guidelines
HbA1c
Hemoglobin A1c
Internal Medicine
Online Exclusive
Physician Assistant
Primary Care
Sponsored Links